Guideline for the treatment of chronic lymphocytic leukaemia-Reference-Cited by-同舟云学术

Guideline for the treatment of chronic lymphocytic leukaemia

Published:2022-03-21 Issue:5 Volume:197 Page:544-557
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Walewska Renata¹,Parry‐Jones Nilima²^ORCID,Eyre Toby A.³^ORCID,Follows George⁴,Martinez‐Calle Nicolas⁵,McCarthy Helen¹,Parry Helen⁶⁷,Patten Piers E. M.⁸⁹,Riches John C.¹⁰^ORCID,Hillmen Peter¹¹¹²^ORCID,Schuh Anna H.³¹³

Affiliation:

1. Department of Haematology University Hospitals Dorset Bournemouth UK

2. Department of Haematology Aneurin Bevan University Health Board Wales UK

3. Department of Haematology, Cancer and Haematology Centre Oxford University Hospitals NHS Foundation Trust Oxford UK

4. Department of Haematology Addenbrookes Cambridge UK

5. Clinical Haematology Nottingham University Hospitals NHS Trust Nottingham UK

6. Institute of Immunology and Immunotherapy University of Birmingham Birmingham UK

7. University Hospitals Birmingham NHS Trust Birmingham UK

8. Comprehensive Cancer Centre School of Cancer and Pharmaceutical Sciences, King’s College London London UK

9. Department of Haematology King’s College Hospital NHS Trust London UK

10. Centre for Haemato‐Oncology, Barts Cancer Institute Queen Mary University of London London UK

11. St. James's Institute of Oncology Leeds UK

12. Leeds Institute of Cancer and Pathology University of Leeds Leeds UK

13. Department of Oncology University of Oxford, John Radcliffe Hospital Oxford UK

Funder

British Society for Haematology

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.18075

Reference82 articles.

1. Guideline for the treatment of chronic lymphocytic leukaemia

2. Management of cardiovascular complications of bruton tyrosine kinase inhibitors

3. Richter transformation of chronic lymphocytic leukaemia: a British Society for Haematology Good Practice Paper

4. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelines

5. Comorbid conditions and survival in unselected, newly diagnosed patients with chronic lymphocytic leukemia

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-life diagnostic and therapeutic approach to CLL: a 2022 update from an expert panel in Tuscany;Clinical and Experimental Medicine;2023-11-18

2. COVID-19 in Patients with Chronic Lymphocytic Leukemia: What Have We Learned?;Acta Haematologica;2023-10-11

3. Metabolic and toxicological considerations for phosphoinositide 3-kinase delta inhibitors in the treatment of chronic lymphocytic leukemia;Expert Opinion on Drug Metabolism & Toxicology;2023-09-02

4. Immune Dysfunction and Infection – Interaction between CLL and Treatment: A Reflection on Current Treatment Paradigms and Unmet Needs;Acta Haematologica;2023-07-27

5. SF3B1 Mutations Are Associated with Resistance to Non-Genotoxic MDM2 Inhibition in Chronic Lymphocytic Leukemia;International Journal of Molecular Sciences;2023-07-12